Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 15Sarcoma, Ewing 10Neuroblastoma 7Rhabdomyosarcoma 6Osteosarcoma 6Gliosarcoma 6Glioblastoma 6Brain Neoplasms 6Astrocytoma 6Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Central Nervous System Neoplasms 5Glioma 4Wilms Tumor 3Sarcoma, Clear Cell 3Rhabdoid Tumor 3Recurrence 3Desmoplastic Small Round Cell Tumor 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Testicular Neoplasms 2Retinoblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Optic Nerve Glioma 2Oligodendroglioma 2Myoepithelioma 2Meningeal Carcinomatosis 2Malignant mesenchymal tumor 2Lymphoma 2

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 5Radiotherapy 5Surgical Procedures, Operative 3Imatinib Mesylate 3Biopsy 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3sargramostim 2Tamoxifen 2Donepezil 2Congresses as Topic 2Cisplatin 2Carboplatin 2temsirolimus 1lonafarnib 1gallium Ga 68 dotatate 1fluorodopa F 18 1entinostat 1carboxyamido-triazole 1aldesleukin 1Vinblastine 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma, Subependymal × Topotecan × Sarcoma × Clear all
NCT00541138 2011-09-21

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

City of Hope Medical Center

Phase 2 Completed
50 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡